3-Amidinophenylalanine-derived matriptase inhibitors can modulate hepcidin production in vitro

Erzsébet Pászti-Gere, Gergely Szombath, Michael Gütschow, Torsten Steinmetzer, András Székács

Research output: Article

Abstract

Matriptase-2 (MT-2) is a type II transmembrane serine protease and predominantly attached to the surface of hepatocytes. MT-2 decreases the production of hepcidin, a key regulator of iron homeostasis. In this study, the effects of four 3-amidinophenylalanine-derived combined matriptase-1/matriptase-2 (MT-1/2) inhibitors (MI-432, MI-441, MI-460, and MI-461) on hepcidin production were investigated in hepatocyte mono- and hepatocyte-Kupffer cell co-cultures. In MI-461-treated cell cultures, the extracellular hydrogen peroxide contents and the interleukin-6 and -8 (IL-6 and IL-8) levels were determined and compared to controls. Hepcidin overproduction was observed in hepatocytes upon treatment with MI-432, MI-441 and MI-461 at 50 μM. In contrast, extracellular hydrogen peroxide levels were not elevated significantly after matriptase inhibition with MI-461. Furthermore, MI-461 did not induce increases in IL-6 and IL-8 levels in these hepatic models. A model of the binding mode of inhibitor MI-461 in complex with MT-2 revealed numerous polar contacts contributing to the nanomolar potency of this compound. Based on the in vitro data on hepcidin regulation, treatment with MI-461 might be valuable in pathological states of iron metabolism without causing excessive oxidative stress.

Original languageEnglish
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
DOIs
Publication statusAccepted/In press - jan. 1 2019

Fingerprint

Hepcidins
Hepatocytes
Interleukin-8
Interleukin-6
Hydrogen Peroxide
Iron
Cell Culture Techniques
Kupffer Cells
Serine Proteases
Coculture Techniques
Oxidative Stress
Homeostasis
matriptase
matriptase 2
In Vitro Techniques
Liver

ASJC Scopus subject areas

  • Pharmacology

Cite this

3-Amidinophenylalanine-derived matriptase inhibitors can modulate hepcidin production in vitro. / Pászti-Gere, Erzsébet; Szombath, Gergely; Gütschow, Michael; Steinmetzer, Torsten; Székács, András.

In: Naunyn-Schmiedeberg's Archives of Pharmacology, 01.01.2019.

Research output: Article

@article{b53449ffd47d4e1aa95163191116f6db,
title = "3-Amidinophenylalanine-derived matriptase inhibitors can modulate hepcidin production in vitro",
abstract = "Matriptase-2 (MT-2) is a type II transmembrane serine protease and predominantly attached to the surface of hepatocytes. MT-2 decreases the production of hepcidin, a key regulator of iron homeostasis. In this study, the effects of four 3-amidinophenylalanine-derived combined matriptase-1/matriptase-2 (MT-1/2) inhibitors (MI-432, MI-441, MI-460, and MI-461) on hepcidin production were investigated in hepatocyte mono- and hepatocyte-Kupffer cell co-cultures. In MI-461-treated cell cultures, the extracellular hydrogen peroxide contents and the interleukin-6 and -8 (IL-6 and IL-8) levels were determined and compared to controls. Hepcidin overproduction was observed in hepatocytes upon treatment with MI-432, MI-441 and MI-461 at 50 μM. In contrast, extracellular hydrogen peroxide levels were not elevated significantly after matriptase inhibition with MI-461. Furthermore, MI-461 did not induce increases in IL-6 and IL-8 levels in these hepatic models. A model of the binding mode of inhibitor MI-461 in complex with MT-2 revealed numerous polar contacts contributing to the nanomolar potency of this compound. Based on the in vitro data on hepcidin regulation, treatment with MI-461 might be valuable in pathological states of iron metabolism without causing excessive oxidative stress.",
keywords = "Extracellular ROS, Hepatocytes, Hepcidin, Hydrogel matrix, Matriptase inhibitors",
author = "Erzs{\'e}bet P{\'a}szti-Gere and Gergely Szombath and Michael G{\"u}tschow and Torsten Steinmetzer and Andr{\'a}s Sz{\'e}k{\'a}cs",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s00210-019-01743-x",
language = "English",
journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",
issn = "0028-1298",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - 3-Amidinophenylalanine-derived matriptase inhibitors can modulate hepcidin production in vitro

AU - Pászti-Gere, Erzsébet

AU - Szombath, Gergely

AU - Gütschow, Michael

AU - Steinmetzer, Torsten

AU - Székács, András

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Matriptase-2 (MT-2) is a type II transmembrane serine protease and predominantly attached to the surface of hepatocytes. MT-2 decreases the production of hepcidin, a key regulator of iron homeostasis. In this study, the effects of four 3-amidinophenylalanine-derived combined matriptase-1/matriptase-2 (MT-1/2) inhibitors (MI-432, MI-441, MI-460, and MI-461) on hepcidin production were investigated in hepatocyte mono- and hepatocyte-Kupffer cell co-cultures. In MI-461-treated cell cultures, the extracellular hydrogen peroxide contents and the interleukin-6 and -8 (IL-6 and IL-8) levels were determined and compared to controls. Hepcidin overproduction was observed in hepatocytes upon treatment with MI-432, MI-441 and MI-461 at 50 μM. In contrast, extracellular hydrogen peroxide levels were not elevated significantly after matriptase inhibition with MI-461. Furthermore, MI-461 did not induce increases in IL-6 and IL-8 levels in these hepatic models. A model of the binding mode of inhibitor MI-461 in complex with MT-2 revealed numerous polar contacts contributing to the nanomolar potency of this compound. Based on the in vitro data on hepcidin regulation, treatment with MI-461 might be valuable in pathological states of iron metabolism without causing excessive oxidative stress.

AB - Matriptase-2 (MT-2) is a type II transmembrane serine protease and predominantly attached to the surface of hepatocytes. MT-2 decreases the production of hepcidin, a key regulator of iron homeostasis. In this study, the effects of four 3-amidinophenylalanine-derived combined matriptase-1/matriptase-2 (MT-1/2) inhibitors (MI-432, MI-441, MI-460, and MI-461) on hepcidin production were investigated in hepatocyte mono- and hepatocyte-Kupffer cell co-cultures. In MI-461-treated cell cultures, the extracellular hydrogen peroxide contents and the interleukin-6 and -8 (IL-6 and IL-8) levels were determined and compared to controls. Hepcidin overproduction was observed in hepatocytes upon treatment with MI-432, MI-441 and MI-461 at 50 μM. In contrast, extracellular hydrogen peroxide levels were not elevated significantly after matriptase inhibition with MI-461. Furthermore, MI-461 did not induce increases in IL-6 and IL-8 levels in these hepatic models. A model of the binding mode of inhibitor MI-461 in complex with MT-2 revealed numerous polar contacts contributing to the nanomolar potency of this compound. Based on the in vitro data on hepcidin regulation, treatment with MI-461 might be valuable in pathological states of iron metabolism without causing excessive oxidative stress.

KW - Extracellular ROS

KW - Hepatocytes

KW - Hepcidin

KW - Hydrogel matrix

KW - Matriptase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=85074653978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074653978&partnerID=8YFLogxK

U2 - 10.1007/s00210-019-01743-x

DO - 10.1007/s00210-019-01743-x

M3 - Article

C2 - 31659405

AN - SCOPUS:85074653978

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

SN - 0028-1298

ER -